The European Medicines Agency (EMA) is hosting a workshop on 30 November to discuss the benefits and impact of early regulatory interactions and incentives for the development of medicines for rare diseases.
The workshop is designed to facilitate and encourage early dialogue between developers and regulators to develop innovative medicines in neglected disease areas.
The workshop will be held virtually and can be followed via live broadcast.
In order to participate in the workshop, participants will need to complete the online form. Please see the related link for more information on the workshop including the agenda.